A Creasey - JoVE Visualize

Showing results (51-60 of 86) with videos related to

Pageof 9

Sort By:

Cancer Research|January 1, 1976

Clinical effects and pharmacokinetics of different dosage schedules of adriamycinW A Creasey, L S McIntosh, T Brescia, et al.

Molecular Microbiology|December 21, 2002

CesT is a bivalent enteropathogenic Escherichia coli chaperone required for translocation of both Tir and MapElizabeth A Creasey, Robin M Delahay, Alexandra A Bishop, et al.

Cell Reports|November 3, 2021

SdhA blocks disruption of the Legionella-containing vacuole by hijacking the OCRL phosphataseWon Young Choi, Seongok Kim, Philipp Aurass, et al.

Circulatory Shock|February 1, 1991

Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coliA A Creasey, P Stevens, J Kenney, et al.

Infection and Immunity|October 1, 1993

Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation patternJ P de Boer, A A Creasey, A Chang, et al.

European Cytokine Network|January 1, 1994

Soluble IL-2 receptor beta and gamma subunits: ligand binding and cooperativityK Johnson, Y Choi, Z Wu, et al.

Hybridoma|August 1, 1987

Murine monoclonal antibodies defining neutralizing epitopes on tumor necrosis factorB M Fendly, K J Toy, A A Creasey, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988

Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicinC Dollbaum, A A Creasey, S H Dairkee, et al.

Critical Care (London, England)|March 17, 2009

A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumoniaPierre-François Laterre, Steven M Opal, Edward Abraham, et al.

Science (New York, N.Y.)|April 12, 1985

Molecular cloning of the complementary DNA for human tumor necrosis factorA M Wang, A A Creasey, M B Ladner, et al.

Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:

Pageof 9

Cancer Research|January 1, 1976

Clinical effects and pharmacokinetics of different dosage schedules of adriamycinW A Creasey, L S McIntosh, T Brescia, et al.

Molecular Microbiology|December 21, 2002

CesT is a bivalent enteropathogenic Escherichia coli chaperone required for translocation of both Tir and MapElizabeth A Creasey, Robin M Delahay, Alexandra A Bishop, et al.

Cell Reports|November 3, 2021

SdhA blocks disruption of the Legionella-containing vacuole by hijacking the OCRL phosphataseWon Young Choi, Seongok Kim, Philipp Aurass, et al.

Circulatory Shock|February 1, 1991

Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coliA A Creasey, P Stevens, J Kenney, et al.

Infection and Immunity|October 1, 1993

Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation patternJ P de Boer, A A Creasey, A Chang, et al.

European Cytokine Network|January 1, 1994

Soluble IL-2 receptor beta and gamma subunits: ligand binding and cooperativityK Johnson, Y Choi, Z Wu, et al.

Hybridoma|August 1, 1987

Murine monoclonal antibodies defining neutralizing epitopes on tumor necrosis factorB M Fendly, K J Toy, A A Creasey, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988

Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicinC Dollbaum, A A Creasey, S H Dairkee, et al.

Critical Care (London, England)|March 17, 2009

A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumoniaPierre-François Laterre, Steven M Opal, Edward Abraham, et al.

Science (New York, N.Y.)|April 12, 1985

Molecular cloning of the complementary DNA for human tumor necrosis factorA M Wang, A A Creasey, M B Ladner, et al.

Pageof 9